Home/Pipeline/Thrombosis Portfolio (e.g., Arixtra® generics)

Thrombosis Portfolio (e.g., Arixtra® generics)

Prevention/treatment of blood clots

ApprovedCommercial

Key Facts

Indication
Prevention/treatment of blood clots
Phase
Approved
Status
Commercial
Company

About Aspen Pharmacare

Aspen Pharmacare is a leading South African multinational pharmaceutical company with a vast global footprint, improving patient health in over 115 countries through high-quality, affordable medicines. The company operates through two key business segments: Manufacturing and Commercial Pharmaceuticals, with a diverse portfolio covering sterile injectables, oral solid doses, liquids, semi-solids, biologicals, and active pharmaceutical ingredients (APIs). With a strong leadership team and a commitment to integrity and innovation, Aspen holds manufacturing approvals from stringent global regulatory agencies like the US FDA, positioning it as a significant player in the global generics and specialty pharma market.

View full company profile